Survival after neoadjuvant chemoradiotherapy and oesophagectomy versus definitive chemoradiotherapy for patients with oesophageal squamous cell carcinoma
ConclusionNeoadjuvant chemoradiotherapy and oesophagectomy is associated with better overall survival than dCRT in patients with stage II and III oesophageal SCC.
Source: British Journal of Surgery - Category: Surgery Authors: B. ‐Y. Wang,
S.‐C. Wu,
H.‐C. Chen,
W.‐H. Hung,
C.‐H. Lin,
C.‐L. Huang,
H.‐S. Chen Tags: Original article Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Esophagus Cancer | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Skin Cancer | Squamous Cell Carcinoma | Surgery | Taiwan Health | UK Health